mRNA cancer vaccines: Advances, trends and challenges

Patients exhibit good tolerance to messenger ribonucleic acid (mRNA) vaccines, and the choice of encoded molecules is flexible and diverse. These vaccines can be engineered to express full-length antigens containing multiple epitopes without major histocompatibility complex (MHC) restriction, are re...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Qing, Gao, Hua, Tan, Dejiang, Zhang, Heng, Wang, Jun-zhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942458/
https://www.ncbi.nlm.nih.gov/pubmed/35345451
http://dx.doi.org/10.1016/j.apsb.2022.03.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942458/
https://www.ncbi.nlm.nih.gov/pubmed/35345451
http://dx.doi.org/10.1016/j.apsb.2022.03.011

Ejemplares similares